Quest PharmaTech Competitors and Similar CompaniesClear all
Quest PharmaTech's competitors and similar companies include Alligator Bioscience and Xilio Therapeutics.
 Quest PharmaTech Quest PharmaTech is a pharmaceutical company that develops drugs with a focus on the treatment of cancer. |  Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. | ||
Founding Date | Founding Date N/A | Founding Date 2001 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Edmonton, CA HQ | Locations Lund, SE HQ | Locations Waltham, US HQ |
Employees | Employees N/A | Employees 1555% decrease | Employees 69 |
Valuation ($) | Valuation ($) 3 m | Valuation ($) 59 m | Valuation ($) 43.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr514k (FY, 2025) | Revenue (est.) $43.8m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit kr1.1m (FY, 2025) | Gross profit N/A |
Net income | Net income ($1.8m) (FY, 2025) | Net income (kr51.4m) (FY, 2025) | Net income ($35m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Alligator Bioscience
HQ
Lund, SE
Employees
15
Alligator develops antibody-based pharmaceuticals for cancer treatment.
View companyXilio Therapeutics
HQ
Waltham, US
Employees
69
Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
View company